Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC).
Saved in:
| Title: | Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC). |
|---|---|
| Authors: | Jacoby, Meagan A.1 (AUTHOR), Finn, Laura2 (AUTHOR), Emadi, Ashkan3 (AUTHOR), Saba, Nakhle S.4 (AUTHOR), Powell, Bayard L.5 (AUTHOR), Seiter, Karen6 (AUTHOR), Garcia, Rosella7 (AUTHOR), Faderl, Stefan7 (AUTHOR), Male, Heather J.8 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Oct 2021, Vol. 62 Issue 10, p2539-2542. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
